Email updates

Keep up to date with the latest news and content from RB&E and BioMed Central.

Open Access Research

Human prolyl hydroxylase expression in uterine leiomyoma during the menstrual cycle

Masaaki Iwahashi1*, Yasuteru Muragaki2 and Kazuhiko Ino1

Author Affiliations

1 Department of Obstetrics and Gynecology, Wakayama Medical University, Wakayama, 641-0012, Japan

2 Department of Pathology, Wakayama Medical University, Wakayama, 641-0012, Japan

For all author emails, please log on.

Reproductive Biology and Endocrinology 2012, 10:111  doi:10.1186/1477-7827-10-111


The electronic version of this article is the complete one and can be found online at: http://www.rbej.com/content/10/1/111


Received:23 June 2012
Accepted:13 November 2012
Published:17 December 2012

© 2012 Iwahashi et al.; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

To investigate the role of prolyl hydroxylase (PH), a key enzyme of collagen synthesis, in human uterine leiomyoma, PH expression was determined in the normal uterine myometrium and the leiomyoma tissues during the menstrual cycle.

Methods

The tissues were obtained from 40 regularly cycling women (aged 29 to 53 yr) who were undergoing abdominal hysterectomy for symptomatic uterine leiomyoma. Immunohistochemistry for human PH with specific monoclonal antibody was used for analysis.

Results

Immunohistochemical staining for PH revealed intense staining of leiomyoma cells in the uterine leiomyoma throughout the menstrual cycle, as compared with the adjacent normal myometrium. In the secretory phase, weak or no immunostaining for PH was detected in the normal myometrial tissues.

Conclusions

These results suggest that increased expression of PH might play an role in the physiology of uterine leiomyoma during the menstrual cycle.

Keywords:
Prolyl hydroxylase; Human uterine myometrium; Leiomyoma; Immunohistochemistry

Background

The extracellular matrix (ECM) is considered to play an important role in the stability of tissues and in regulating the growth and differentiation of cells [1,2].

Synthesis, accumulation, and catabolism of the ECM occur during wound healing and during the initiation and progression of numerous diseases [3]. Moreover, it is generally acknowledged that the ECM does not function as a mere passive scaffold for connective tissue within organ architecture. It is also suggested that ECM plays an ‘informational’ role through a network of interactions between cells and signal molecules that is of primary importance in the control of cellular proliferation and motility during histogenesis, for the maintenance of tissue homeostasis and in cancer development. The ECM of uterine leiomyoma has been studied [4-7], but changes of the collagen metabolism in uterine tissues are not fully understood. Therefore, the precise control of ECM metabolism in the uterine myoma and myometrium is critical for understanding the pathophysiology and development of uterine leiomyoma.

Most of the 4-hydroxyproline in mammalian proteins is found in the -X-4Hyp-Gly- sequences of the 29 currently known collagen types and more than 20 additional proteins with collagen–like triple-helical domains [8,9]. 4-Hydroxyproline residues have a vital role in providing the collagen triple helices with thermal stability. Non-hydroxylated collagen polypeptide chains cannot form functional molecules in vitro, and almost complete hydroxylation of the proline residues in –X-Pro-Gly- triplets is required for the generation of a molecule that is stable at human body temperature. This hydroxylation is catalyzed by collagen prolyl hydroxylase (PH) located within the lumen of the endoplasmic reticulum [10]. Therefore, in the present study, we investigated the distribution of human PH, a key enzyme in the synthesis of collagen [11,12], in human uterine leiomyoma by immunofluorescent staining.

Methods

This project was approved by the Committee on Investigations Involving Human Subjects of Wakayama Medical University. Informed consent was obtained from each subject after the purpose and nature of the study had been fully explained.

Tissues

Leiomyomas and matched myometrium were processed for immunohistochemistry. The tissues were obtained from 40 premenopausal regularly cycling women (aged 29 to 53 yr) who were undergoing abdominal hysterectomy for symptomatic uterine leiomyoma. None of the patients received any hormone therapy before operation. The stage of menstrual cycle was determined by histological dating of the endometrium for all secretory phase samples. Proliferative phase samples were dated by either dating of the endometrium or date of last menstrual period. The leiomyoma and corresponding myometrium specimens from the proliferative (n = 20) and secretory (n = 20) phase were studied. No submucosal leiomyomas were collected so as to avoid possible contamination with endometrium. Three distant samples were collected from each leiomyoma and adjacent normal myomerial tissues. These tissues were immediately frozen in liquid nitrogen.

Primary antibodies

We used the monoclonal antibodies (mAbs) against of hPH (anti-hPH(β); horseradish peroxidase-conjugated Fab’ (Fab’-HRP)), which recognized the β subunit of prolyl hydroxylase, were prepared as described by Bai et al. [13]. Preparation of the antibodies has been performed as described previously [14]. The specificity of the antibodies was determined by immunoblotting or by inhibition in an enzyme-linked immunosorbent assay.

Immunohistochemistry

Immunohistochemical analysis was performed by the standard indirect immunofluorescence method. In brief, 3-μm frozen sections were rehydrated in phosphate-buffered saline (PBS) at room temperature and then incubated with the primary antibody (diluted 1: 100 in PBS) for 12 h at 4°C in a humidified chamber. After incubation, the sections were washed twice in PBS for 3 min. Each section was then incubated for 1 h at room temperature with human plasma-preabsorbed, fluorescein isothiocyanate-conjugated goat antibodies against mouse immunoglobulins diluted 1:100 in PBS (Organon Teknik, Co., West Chester, PA).

Control sections were stained with goat antibodies against mouse immunoglobulin G without prior application of the primary antibodies. No immunofluorescence was recognized in control sections (Figure 1A). When the mAb was first allowed to react with an excess of hPH , no immunostaining was observed (data not shown).

thumbnailFigure 1. Immunofluorescence micrographs of human uterine leiomyoma and myometrium with immunostaining by mAbs specific for human PH. The micrographs of leiomyoma are B and D, and the micrographs of myometrium are C and E during the menstrual cycle (proliferative phase: B and C; secretory phase: D and E). No immunofluorescence was recognized in the control section (A). (Original magnification, X 125) Scale bar represents 50 μm.

Results

Immunostaining with the mAbs against hPH showed intense granular pattern in the cytoplasm of leiomyoma cells as compared with the normal uterine myometrial tissues throughout the menstrual cycle consistently (Figure 1B and D). Immunostaining for hPH showed intense granular pattern in the cytoplasm of the normal myometrial cells in the proliferative phase (Figure 1C). However, weak or no immunostaining for hPH was detected in the normal myometrial tissues in the secretory phase (Figure 1E).

The intensity of staining of the uterine tissues from the menstrual cycle by the antibodies against hPH was subjectively graded from 1+ to 3+ and the results are summarized in Table 1.

Table 1. Immunostaining with antibodies for human prolyl hydroxylase in the human uterine leiomyoma and myometrium

Discussion

In the present study, we investigated the immunolocalization of hPH in the human uterine tissues obtained during the menstrual cycle. Immunostaining for hPH was clearly apparent in the cytoplasm of the uterine leiomyoma cells and the normal myometrial cells during the menstrual cycle. Especially, in the uterine leiomyoma, the strong expression of hPH was detected, as compared with the normal adjacent myometrium during the menstrual cycle. These findings suggest that leiomyoma cells might synthesize collagens more actively than the normal myometrial cells throughout the menstrual cycle consistently.

We have previously suggested that the increased expression of the various collagens, such as type III, IV and V collagens, is recognized by immunohistochemistry and sodium dodecyl sulfate-polyacrylamide gel electrophoresis in the human uterine leiomyoma, as compared with the normal uterine myometrium during the menstrual cycle [15,16]. Therefore, increased these collagens expression might play an important role in the morphologic and functional characteristics of human uterine leiomyoma.

PH, a key enzyme in the hydroxylation of proline to hydroxyproline during the synthesis of collagen [11,12], is a tetramer of two α and β subunits [17]. A cDNA sequence for the β subunit of hPH has been found to be highly homologous with that for a rat protein disulfide isomerase, which is regarded as the catalyst in vivo for formation of disulfide bonds in the biosynthesis of various secretory proteins [17,18]. Therefore, immunoreactivity of the β subunit may reflect the enzymatic activity of PH in collagen metabolism.

Recently, it has been suggested that oxygen-dependent hydroxylation of hypoxia-inducible factor (HIF)- α subunits by PH domain (PHD) proteins signals their polyubiquitination and proteasomal degradation, and a critical role in regulating HIF abundance and oxygen homeostasis. While oxygen concentration plays a major role in determining the efficiency of PHD-catalyzed hydroxylation reactions, many other environmental and intracellular factors also significantly modulate PHD activities. In addition, PHDs may also employ hydroxylase-independent mechanisms to modify HIF activity. Functionally, different PHD isoforms may differentially contribute to specific pathophysiological processes, including angiogenesis, erythropoiesis, tumorigenesis, diabetes, and cell growth, differentiation and survival [10,19-25]. Therefore, our findings support the hypothesis that HIF-PH systems might be involved in the pathogenesis of uterine leiomyoma during the menstrual cycle [26,27].

Conclusions

An increased hPH expression was found in the uterine leiomyoma cells of the uterine fibroids throughout the menstrual cycle. Thus, these consistent expression of hPH might play a role in the physiology of human uterine fibroids.

This study provides some clues to understanding the pathogenesis of human uterine leiomyoma in terms of the, ECM metabolism. Further work is needed to elucidate the mechanisms regulating the HIF-PH expression in the human uterus during the menstrual cycle and the medical treatments.

Abbreviations

ECM: Extracellular matrix; HIF: Hypoxia-inducible factor; Mabs: Monoclonal antibodies; PBS: Phosphate-buffered saline; PH: Prolyl hydroxylase.

Competing interest

The authors have no competing interest to declare.

Authors’ contributions

MI carried out the Immunohistochemical studies, and participated in the design and drafted the manuscript. YM carried out the production of the monoclonal antibodies and evaluated the result of immunohistochemical staining. KI participated in the design of the study, and conceived of the study, and participated in its design and consideration and drafted the manuscript. All authors have read and approved the final manuscript.

Authors’ information

MI is the assistant professor of the Obstetrics and Gynecology in Wakayama Medical University. YM is the professor of the Pathology in Wakayama Medical University. KI is the professor of the Obstetrics and Gynecology in Wakayama Medical University.

References

  1. Lin CQ, Bissell MJ: Multi-faceted regulation of cell differentiation by extracellular matrix.

    FASEB J 1993, 7:737-743. PubMed Abstract | Publisher Full Text OpenURL

  2. Madri JA, Basson MD: Extracellular matrix-cell interactions: dynamic modulators of cell, tissue and organism structure and function.

    Lab Invest 1992, 66:519-521. PubMed Abstract OpenURL

  3. Haralson MA: Extracellular matrix and growth factors: an integrated interplay controlling tissue repair and progression to disease.

    Lab Invest 1993, 69:369-372. PubMed Abstract OpenURL

  4. Ferency A, Richart RM, Okazaki T: A comparative ultrastructural study of leiomyosarcoma, cellular leiomyoma, and leiomyoma of the uterus.

    Cancer 1971, 28:1004-1018. PubMed Abstract | Publisher Full Text OpenURL

  5. Srewart AE, Friedman AJ, Peck K, Nowak RA: Relative overexpression of collagen type I and collagen III messenger ribonucleic acids by uterine leiomyoma during the proliferative phase of the menstrual cycle.

    J Clin Endocrinol Metab 1994, 79:900-906. PubMed Abstract | Publisher Full Text OpenURL

  6. Catherino WH, Leppert PC, Stenmark MH, Payson M, Potiog-Nahari C, Nieman LK, Segars JH: Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids.

    Gene Chromosome Canc 2004, 40:204-217. Publisher Full Text OpenURL

  7. Leppert PC, Baginski T, Prupas C, Catherino WH, Pletcher S, Segars JH: Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium.

    Fertil Steril 2004, 82(suppl3):1182-1187. PubMed Abstract | Publisher Full Text OpenURL

  8. Myllyharju J, Kivirikko KI: Collagen, modifying enzymes and their mutations in humans, files and worms.

    Trends Genet 2004, 20:33-43. PubMed Abstract | Publisher Full Text OpenURL

  9. Veit G, Kobbe B, Keene DR, Paulsson M, Koch M, Wagener R: Collagen XXVIII, a novel von Willebrand factor A domain-containing protein with many imperfections in the collagenous domain.

    J Biol Chem 2006, 281:3494-3504. PubMed Abstract | Publisher Full Text OpenURL

  10. Myllyharju J: Prolyl 4-hydroxylases, key enzymes in the synthesis of collagens and regulation of the response to hypoxia, and their roles as treatment targets.

    Ann Med 2008, 40:402-417. PubMed Abstract | Publisher Full Text OpenURL

  11. Rhodes RE, Udenfriend S: Purification and properties of collagen proline hydroxylae from newborn rat skin.

    Arch Biochem Biophys 1970, 139:329-390. PubMed Abstract | Publisher Full Text OpenURL

  12. Cardinale GJ, Udenfriend S: Prolyl hydroxylase.

    Adv Enzymol 1974, 41:245-330. PubMed Abstract OpenURL

  13. Bai Y, Muragaki Y, Obata K, Iwata K, Ooshima A: Immunological properties of monoclonal antibodies to human and rat 4-prolyl hydroxylase.

    J Biochem 1986, 99:1563-1570. PubMed Abstract | Publisher Full Text OpenURL

  14. Ooshima A, Muragaki Y: Collagen metabolism in atherogenesis.

    Ann N Y Acad Sci 1990, 598:582-584. PubMed Abstract | Publisher Full Text OpenURL

  15. Iwahashi M, Muragaki Y, Ikoma M, Mabuchi Y, Kobayashi A, Tanizaki Y, Ino K: Immuohistochemical analysis of collagen expression in uterine myomata during the menstrual cycle.

    Exp Ther Med 2011, 2:287-290. PubMed Abstract | PubMed Central Full Text OpenURL

  16. Iwahashi M, Muragaki Y: Increased type I and V collagen expression in uterine leiomyoma during the menstrual cycle.

    Fertil Steril 2011, 95:2137-2139. PubMed Abstract | Publisher Full Text OpenURL

  17. Kivirikko KI, Myllyla R, Pihlajaniemi T: Protein hydroxylation: prolyl 4-hydroxylase, an enzyme with four cosubstrates and a multifunctional subunit.

    FASEB J 1989, 3:1609-1617. PubMed Abstract | Publisher Full Text OpenURL

  18. Edman JC, Ellis L, Blacher RW, Roth RA, Rutter WJ: Sequence of protein disulfide isomerase and implication of its relationship to thioredoxin.

    Nature 1989, 317:267-270. OpenURL

  19. Fong G-H, Takeda K: Role and regulation of prolyl hydroxylase domain proteins.

    Cell Death Differ 2008, 10:635-641. OpenURL

  20. Rakesh KJ: A new target for tumor therapy.

    N Engl J Med 2009, 360:2669-2671. PubMed Abstract | Publisher Full Text OpenURL

  21. Fraisl P, Aragones J, Carmeliet P: Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease.

    Nat Rev Drug Discov 2009, 8:139-152. PubMed Abstract | Publisher Full Text OpenURL

  22. Semenza GL: Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis.

    Blood 2009, 114:2015-2019. PubMed Abstract | Publisher Full Text OpenURL

  23. Fong G-H: Regulation of angiogenesis by oxygen sensing mechanisms.

    J Mol Med 2009, 87:549-560. PubMed Abstract | Publisher Full Text OpenURL

  24. Nizet V, Johnson RS: Interdependence of hypoxic and innate immune responses.

    Nat Rev Immunol 2009, 9:609-617. PubMed Abstract | Publisher Full Text OpenURL

  25. Aprelikova O, Pandolfi S, Tackett S, Ferreira M, Salnikow K, Ward Y, Lisinger JI, Barrett JC, Niederhuber J: Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response.

    Cancer Res 2009, 69:616-624. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  26. Mayer A, Hoeckel M, Wree A, Leo C, Horn LC, Vaupel P: Lack of hypoxic response in uterine leiomyomas despite severe tissue hypoxia.

    Cancer Res 2008, 68:4719-4726. PubMed Abstract | Publisher Full Text OpenURL

  27. Mayer A, Hoeckel M, von Wallbrunn A, Horn LC, Wree A, Vaupel P: HIF-mediated hypoxic response is missing in severely hypoxic uterine leiomyomas.

    Adv Exp Med Biol 2010, 662:399-405. PubMed Abstract | Publisher Full Text OpenURL